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Pigs as Source  
for Toxigenic 
Corynebacterium 
ulcerans
To the Editor: Toxigenic Coryne-
bacterium  ulcerans  may  cause  a 
zoonotic infection similar to diphthe-
ria  caused  by  C.  diphtheriae.  Previ-
ously, dairy cattle were considered to 
be the main reservoir for C. ulcerans 
(1), but recent publications suggest pet 
dogs and pet cats as carriers (cats of-
ten show bilateral nasal discharge) (2). 
We report a case of severe C. ulcer-
ans diphtheria-like disease in a person 
who had had contact with pigs.
In December 2007, a previously 
healthy  56-year-old  female  farmer 
was  admitted  to  the  Ear,  Nose  and 
Throat Department of the University 
Hospital Erlangen with a 1-week his-
tory  of  sore  throat  and  progressive 
dysphagia. She did not report fever 
and had not received prior treatment 
with  antimicrobial  drugs.  She  had 
thick,  whitish  pseudomembranes  on 
her uvula, pharynx, and both tonsils. 
Endoscopic  examination  of  her  lar-
ynx  and  hypopharynx  showed  that 
both vocal cords were mobile and the 
mucosa was erythematous. Enlarged 
cervical lymph nodes were palpable 
on both sides of her neck. She had 
no  signs  of  cranial  nerve  palsies. 
Her  temperature  was  36.5°C.  Be-
cause of the extensive oropharyngeal 
pseudomembranes,  diphtheria  was 
suspected  and  diphtheria  antitoxin 
(30,000 IU) was administered intra-
muscularly. The patient was isolated 
and received intravenous penicillin (5 
million units 4×/day).
A pharyngeal swab obtained from 
below the whitish pseudomembranes 
grew  toxigenic  C.  ulcerans.  Species 
identification  was  achieved  by  bio-
chemical differentiation (API Coryne 
code 0111326), rpoB sequencing (3), 
and MALDI-TOF analysis (Microflex 
LT and Biotyper 2.0 Software; Bruker 
Daltonics, Bremen, Germany). Toxi-
genicity of the strain, named KL126, 
was  verified  by  using  a  C.  diphthe-
riae  tox–PCR  (4–6),  a  C.  ulcerans 
tox–specific  PCR  (4),  and  the  Elek 
test as described previously (4,5). The 
tox  sequence  (GenBank  accession 
no.  FJ858272)  differs  from  2  other 
published C. ulcerans tox sequences 
(AB304279.1  and  AY703827.1)  at 
only 3 bp.
The patient recovered quickly, and 
the pseudomembranes vanished within 
2 days. However, because an allergic 
rash had developed after her third day 
of  treatment  with  penicillin,  antimi-
crobial drug treatment was switched 
to intravenous erythromycin (500 mg 
4×/d). When 1 day later the standard-
ized  antibiogram  showed  resistance 
to erythromycin, the patient received 
intravenous ceftriaxone (2 g 1×/d) for 
12 days. Seven days after initiation of 
antimicrobial drug therapy, pharynge-
al swabs were taken on 3 consecutive 
days. Because C. ulcerans no longer 
grew on culture, the patient was dis-
charged from the hospital. However, 
2  days  later  she  was  readmitted  to 
hospital  for  severe  polyneuropathy 
with neuralgia and weakness of both 
arms, acute difficulty swallowing, and 
hoarseness. Signs of cardiomyopathy, 
including sinus bradycardia and grade 
I atrioventricular block, were present. 
The patient recovered after symptom-
atic treatment and returned home after 
2 weeks. According to her records, the 
patient had received a basic vaccina-
tion against diphtheria in 1960 and a 
booster in 1998.
The literature describes the clas-
sic  animal  sources  for  toxigenic  C. 
ulcerans as dairy cattle with mastitis 
(1). Since 2005, toxigenic C. ulcerans 
carriage in companion animals, e.g., 
pet cats and dogs, has been reported 
(2).  Two  cases  of  transmission  of  a 
toxigenic C. ulcerans strain from pet 
dogs  to  their  immunocompromised 
female owners have been documented 
in France (7,8). In 2008, toxigenic C. 
ulcerans in 2 dead killer whales from 
a Japanese zoo was reported (9).
To determine the source of our 
patient’s illness, an outbreak investi-
gation involving her family and their 
farm  animals  was  conducted.  Their 
medium-sized pig-breeding farm was 
located in a remote rural village sur-
rounded by woods; they raised ≈500 
pigs  in  a  nonindustrialized  manner, 
and no piglets were purchased from 
outside the farm. Pharyngeal swabs 
of  3  family  members,  19  pigs,  and 
the  farm  dog  were  analyzed  for  C. 
ulcerans. Although all family mem-
bers and the dog were negative for C. 
ulcerans, 1 of the 19 asymptomatic 
pigs harbored a toxigenic strain of C. 
ulcerans. Sequencing of rpoB and tox 
showed 100% homology between the 
human and the pig strains. Ribotyp-
ing  (10)  confirmed  this  result,  sug-
gesting  the  identity  of  both  strains; 
the obtained ribotype is similar to the 
reported U1 ribotype profile found in 
humans and cats (2).
We report proven transmission of 
a toxigenic C. ulcerans strain between 
a livestock animal and a human, as well 
as harboring of toxigenic C. ulcerans 
in  pigs.  Introduction  of  C.  ulcerans 
from wild animals seems unlikely be-
cause the barn doors were reportedly 
closed at all times. Because handling 
of C. ulcerans–infected pigs may lead 
to diphtheria-like illnesses, studies of 
toxigenic C. ulcerans carriage among 
pigs are needed. Similar to our case, 
diphtheria-like  disease  caused  by  an 
erythromycin- and clindamycin-resis-
tant toxigenic C. ulcerans strain in a 
US patient has been recently (in 2008) 
reported (1). Because current recom-
mendations based on C. diphtheriae–
caused disease consider erythromycin 
as the second-line option for treatment 
or  postexposure  prophylaxis,  these 
findings  highlight  the  importance  of 
antimicrobial-drug susceptibility test-
ing of toxigenic C. ulcerans strains.
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Campylobacter  
jejuni HS:23  
and Guillain-Barré  
Syndrome,  
Bangladesh
To  the  Editor:  Guillain-Barré 
syndrome (GBS) is an acute periph-
eral neuropathy triggered by a preced-
ing  infectious  illness.  Gastroenteritis 
caused  by  Campylobacter  jejuni  is 
the most frequently reported anteced-
ent event (1). In Japan, South Africa, 
China,  and  Mexico,  Campylobacter 
strains with certain Penner heat-stable 
(HS) serotypes, including HS:19 and 
HS:41,  are  overrepresented  among 
isolates  from  GBS  case-patients, 
compared with isolates from enteritis 
case-patients (2,3). Several studies in-
dicate that C. jejuni HS:19 and HS:41 
have a clonal population structure and 
suggest  that  these  serotypes  might 
have unique virulence properties that 
are intricately linked to development 
of GBS (4). However, data from the 
United Kingdom and the Netherlands 
suggest  that  such  virulence  proper-
ties may not be restricted to specific 
HS serotypes because many other se-
rotypes can be cultured from patients 
with GBS (5). We report a non-HS:19 
and non-HS:41 C. jejuni serotype and 
sequence  type  (ST)–3219  that  are 
overrepresented among isolates from 
GBS patients in Bangladesh.
We  conducted  a  prospective 
case-control study of the serotype and 
genotype of C. jejuni associated with 
GBS  in  Bangladesh.  Case-patients 
were 97 persons with GBS admitted 
to  Dhaka  Medical  College  Hospital, 
Bangabandhu Sheikh Mujib Medical 
University,  and  Dhaka  Central  Hos-
pital  during  July  2006–June  2007. 
All  fulfilled  the  diagnostic  criteria 
for GBS of the National Institute of 
Neurological Disorders and Stroke of 
the US National Institutes of Health 
(Bethesda, MD, USA) (6). The control 
group comprised 97 patients with oth-
er neurologic diseases, matched with 